Skip to main content
AAN.com

Abstract

We studied 300 patients, 61% women, with mean age 49.7 years and mean duration of dystonia 7.8 years, to determine the demographic and clinical characteristics of cervical dystonia (CD) and its relationships to other movement disorders. Torticollis was present in 82%, laterocollis in 42%, retrocollis in 29%, and anterocollis in 25%; however, the majority (66%) had a combination of these abnormal postures. Scoliosis was present in 39%, local pain reported by 68%, and 32% had evidence of secondary cervical radiculopathy. In addition to CD, 16% of patients had oral dystonia, 12% mandibular dystonia, 10% hand/arm dystonia, and 10% had blepharospasm. Tremor was noted in 71% of patients; head-neck tremor was present in 60%, and tremor in other body regions was present in 32%. A family history of a movement disorder was present in 44% of the CD patients. Tardive dystonia was the cause in 6%; 11% had posttraumatic dystonia. Anticholinergic drugs provided moderate improvement in 33% of patients, but local intramuscular botulinum toxin injections relieved CD, local pain, or both in over 90% of all treated patients.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 41Number 7July 1991
Pages: 1088
PubMed: 2067638

Publication History

Published online: July 1, 1991
Published in print: July 1991

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Joseph Jankovic, MD
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.
Stuart Leder, MD
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.
Dhyanne Warner, PhD MD; and
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.
Kenneth Schwartz, PA
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Sensitization-Associated Symptoms and Neuropathic-like Features in Patients with Cervical Dystonia and Pain, Journal of Clinical Medicine, 13, 7, (2134), (2024).https://doi.org/10.3390/jcm13072134
    Crossref
  2. Effects of botulinum neurotoxin on regularity of head oscillations in cervical dystonia, Dystonia, 3, (2024).https://doi.org/10.3389/dyst.2024.12347
    Crossref
  3. Tremor in cervical dystonia, Dystonia, 3, (2024).https://doi.org/10.3389/dyst.2024.11309
    Crossref
  4. Pain relief in cervical dystonia following regular long-term botulinum therapy, Russian Journal of Pain, 22, 2, (22), (2024).https://doi.org/10.17116/pain20242202122
    Crossref
  5. Unilateral globus pallidus internus combined contralateral subthalamic nucleus deep brain stimulation in the treatment of cervical dystonia: a case report and literature review, Journal of Aging and Rehabilitation, 1, 2, (36-39), (2024).https://doi.org/10.1097/jagr.0000000000000006
    Crossref
  6. Current use of neurotoxins for alleviating symptoms of cervical dystonia, Expert Review of Neurotherapeutics, 24, 8, (787-797), (2024).https://doi.org/10.1080/14737175.2024.2368638
    Crossref
  7. Stigma, coping strategies, distress and wellbeing in individuals with cervical dystonia: a cross-sectional study, Psychology, Health & Medicine, 29, 7, (1313-1330), (2024).https://doi.org/10.1080/13548506.2024.2305172
    Crossref
  8. Approach to abnormal head posture, Strabismus, (1-7), (2024).https://doi.org/10.1080/09273972.2024.2376554
    Crossref
  9. Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollis, Toxicon, 248, (108035), (2024).https://doi.org/10.1016/j.toxicon.2024.108035
    Crossref
  10. The antisaccadic paradigm: A complementary neuropsychological tool in basal ganglia disorders, Cortex, 178, (116-140), (2024).https://doi.org/10.1016/j.cortex.2024.06.005
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share